iqvia semaglutide tirzepatide prescriptions q3 2024 Doctors and Obesity: Are healthcare professionals ready for the new anti-obesity medications? iqvia glp-1 prescriptions q3 2024

The medication may cause persistent nausea, vomiting, abdominal pain, or fatigue that interferes with daily life

Circulation 142 , 10281039

However, if your diarrhea lasts longer than two weeks without any sign of improvement, its time to talk to your healthcare provider

With her shrinking waistline came some unexpected surprises

The REWIND trial for dulaglutide showed a 12% reduction in major cardiovascular events (heart attack, stroke, or cardiovascular death) over a median of 5.4 years

For a helpful overview of industry practices and community perspectives, many players browse guides hosted by trusted reviewers